Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.920
+0.005 (0.13%)
At close: Jun 18, 2026, 4:00 PM EDT
4.090
+0.170 (4.34%)
After-hours: Jun 18, 2026, 7:47 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.31 billion as of June 18, 2026. Its market cap has decreased by -59.84% in one year.
Market Cap
1.31B
Enterprise Value
2.71B
1-Year Change
-59.84%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.31B, an increase of 330.77%. That is a compound annual growth rate of 29.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.31B | -18.26% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 1.80B |
| Bausch Health Companies | 1.78B |
| Amylyx Pharmaceuticals | 1.74B |
| ANI Pharmaceuticals | 1.69B |
| Harrow | 1.60B |
| Perrigo Company | 1.42B |
| Phibro Animal Health | 1.29B |
| Xeris Biopharma Holdings | 1.20B |